Abbott Laboratories (ABT)

107.90
0.37 0.34
NYSE
Prev Close 107.53
Open 107.08
Day Low/High 106.93 / 108.27
52 Wk Low/High 61.61 / 115.14
Volume 4.67M
Exchange NYSE
Shares Outstanding 1772.36B
Market Cap 191.68B
P/E Ratio 57.53
Div & Yield N.A. (N.A)

Latest News

Jim Cramer: 8 Stocks That Benefit the Most If There's Another Modified Lockdown

Jim Cramer: 8 Stocks That Benefit the Most If There's Another Modified Lockdown

These companies have spent the last six months preparing for a second lockdown betting it will occur.

Jim Cramer: Health Care Stocks, the Election and the Perfect Setup

Jim Cramer: Health Care Stocks, the Election and the Perfect Setup

Right now, the market is furiously trying to price in a Blue Wave, and the health care sector is getting clobbered. But here's how I think things play out.

Does Abbott Labs Still Pass My Test After Earnings?

Does Abbott Labs Still Pass My Test After Earnings?

Diagnostics revenue grew an impressive 38% due to the necessity of Covid-19 testing.

'Inside Day', Electoral Risk, Banking Stocks, Stimulus Immediately Needed

'Inside Day', Electoral Risk, Banking Stocks, Stimulus Immediately Needed

There is a presidential debate on Thursday. The market is being forced to adjust for renewed potential uncertainty.

Jim Cramer: This Is How Stocks Would Fare Under a President Biden

Jim Cramer: This Is How Stocks Would Fare Under a President Biden

I don't pick stocks on politics, but was shocked to see how a majority of our Action Alerts PLUS holdings would perform if Joe Biden wins the White House.

Jim Cramer: Better to Mask and Test Than Wait for Vaccine

Jim Cramer: Better to Mask and Test Than Wait for Vaccine

New rapid tests and the effectiveness of universal mask wearing give hope while we wait on the elusive vaccine.

Jim Cramer: Fly Ahead of the Pack on Boeing

Jim Cramer: Fly Ahead of the Pack on Boeing

People want to wait and see on this beleaguered aviation name, but I don't think you can do that. Here's why.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Neither candidate seems to be the enemy of the market -- at least not yet.

Abbott Labs Stock Could Still Slip Lower

Abbott Labs Stock Could Still Slip Lower

Let's review the charts and indicators.

Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams

Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams

Abbott Labs can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test along with its amazing Navica app.

This Dividend Stock's Got the Right Medicine for Investors

This Dividend Stock's Got the Right Medicine for Investors

AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector.

Abbott Rated New Outperform at Wolfe

Charting the Best Hotels in the Sector

Charting the Best Hotels in the Sector

We grade Choice Hotels, Hilton and Marriott, and check on the opportunities each offers.

Rapid Test, Rapid Dow Rally?

Rapid Test, Rapid Dow Rally?

Here's what I expect to happen to the market near term off this potentially game-changing development.

Jim Cramer: Abbott Labs and the Rally in Travel

Jim Cramer: Abbott Labs and the Rally in Travel

ABT will end the issues of flying and cruising. Of course it's another story when you get there. But boarding will be solved.

If You Like Laggards, Here Are 3 to Consider

If You Like Laggards, Here Are 3 to Consider

These companies will benefit immensely as the country experiences a burst of economic growth.

Market Continues Higher in Front of Big Stock Splits and Dow Rebalancing

Market Continues Higher in Front of Big Stock Splits and Dow Rebalancing

There is major rotational action taking place but the flood of liquidity is preventing any real downside from developing.

Vaccine Chills, Divergent Trails, Fed-flation, Walmart and TikTok: Market Recon

Vaccine Chills, Divergent Trails, Fed-flation, Walmart and TikTok: Market Recon

Plus, Veeva Systems reports stellar results and ups its guidance.

Rotation Unravels Speculative Plays

Rotation Unravels Speculative Plays

Speculative trading in lower-priced stocks has dried up and the small caps have been much tougher.

Jim Cramer: Here Comes the Biggest Test Yet

Jim Cramer: Here Comes the Biggest Test Yet

As the president pins all hopes on a Covid vaccine and shuns tried-and-true prevention efforts, Abbott is offering a rapid test that could be a game changer.

There Are Several Different Market Themes Now

There Are Several Different Market Themes Now

One is Abbott Labs' announcement of a quick and cheap Covid test.

Abbott Labs Soars to New Heights: The Stock's Next Technical Targets

Abbott Labs Soars to New Heights: The Stock's Next Technical Targets

Here's where ABT could be headed next.

Focus on Rotation and Not the Direction of the Indices

Focus on Rotation and Not the Direction of the Indices

It isn't just valuation that is likely to drive rotational action.

Jim Cramer: All These Stocks Are Not Quite 'Dow and Out'

Jim Cramer: All These Stocks Are Not Quite 'Dow and Out'

Let's look at the Dow Jones' swapping of Exxon for Salesforce, Pfizer for Amgen and Raytheon for Honeywell.

Jim Cramer: 'Excuse Selling'

Jim Cramer: 'Excuse Selling'

Let's go over five excuses so you know and are armed with them when they are used and make you faint and weak-handed.

Jim Cramer: An Analyst's Dream

Jim Cramer: An Analyst's Dream

All we have to do is take our cue from companies that boosted their forecasts but their stocks did nothing.

We'll Be Checking on These Corporate Earnings Next Week

Next week the June quarter earnings season maelstrom kicks off with 115 companies, including 32 S&P 500 constituents, reporting their latest quarterly results. In recent days we've seen a number of companies up their outlook for the quarter but we'v...

I Wouldn't Buy Pfizer Shares on This Pop

I Wouldn't Buy Pfizer Shares on This Pop

I would wait until the next down day, and there will be one.